Holger Memmesheimer

Articles by Holger Memmesheimer

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

ByAndrew Crumpton,Adrian Parkinson,Holger Memmesheimer,Svetlana Lyapustina,Kevin Hawkins,David Christopher,Sebastian Kaerger,Bruce Wyka,Andy Rignall,Mary Ann Smith

October 1st 2008

The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.

Latest Updated Articles

Quality by Design for analytical methods for use with orally inhaled and nasal drug products
Published: October 1st 2008 | Updated:

Holger Memmesheimer

Articles by Holger Memmesheimer

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

Latest Updated Articles

Trending on Pharmaceutical Technology

Everything to Know About Pharmaceutical Tariffs in 2025

Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt

Challenges for the Global Manufacturing of Vaccines

Integrating Sustainability into the Core of Pharmaceutical Science

Outsourcing Partners Providing End-to-End Service